Selected research
Industry Research
Carboplatin Injection Industry Research Report 2026
Market perspective
The global Carboplatin Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Carboplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Carboplatin Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Carboplatin Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Carboplatin Injection include Hisun, Yunnan Phytopharmaceutical, Yangzijiang Group, Teva, Shanghai Acebright Pharmaceuticals, Shandong Ruiying, Qilu Pharmaceutical, Mylan and Jiangsu Lianhuan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Carboplatin Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Carboplatin Injection Market by Company
Hisun
Yunnan Phytopharmaceutical
Yangzijiang Group
Teva
Shanghai Acebright Pharmaceuticals
Shandong Ruiying
Qilu Pharmaceutical
Mylan
Jiangsu Lianhuan Pharmaceutical
Fresenius Kabi
Cisen Pharmaceutical
Taj Pharmaceuticals
Hospira(Pfizer)
Bristol-Myers Squibb SA
Carboplatin Injection Segment by Type
10ml:50mg
10ml:100mg
Other
Carboplatin Injection Segment by Application
SCLC
Breast Cancer
Ovarian Cancer
Other
Carboplatin Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carboplatin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Carboplatin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carboplatin Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Carboplatin Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Carboplatin Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Carboplatin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10ml:50mg
- 10ml:100mg
- Other
Applications
- SCLC
- Breast Cancer
- Ovarian Cancer
- Other
Companies covered
- Hisun
- Yunnan Phytopharmaceutical
- Yangzijiang Group
- Teva
- Shanghai Acebright Pharmaceuticals
- Shandong Ruiying
- Qilu Pharmaceutical
- Mylan
- Jiangsu Lianhuan Pharmaceutical
- Fresenius Kabi
- Cisen Pharmaceutical
- Taj Pharmaceuticals
- Hospira(Pfizer)
- Bristol-Myers Squibb SA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Carboplatin Injection Market Size (2021-2032)
- 2.2.2 Global Carboplatin Injection Sales (2021-2032)
- 2.2.3 Global Carboplatin Injection Market Average Price (2021-2032)
- 2.3 Carboplatin Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 10ml:50mg
- 2.3.3 10ml:100mg
- 2.3.4 Other
- 2.4 Carboplatin Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 SCLC
- 2.4.3 Breast Cancer
- 2.4.4 Ovarian Cancer
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Carboplatin Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Carboplatin Injection Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Carboplatin Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Carboplatin Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Carboplatin Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Carboplatin Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Carboplatin Injection, Product Type & Application
- 3.8 Global Manufacturers of Carboplatin Injection, Established Date
- 3.9 Global Carboplatin Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Hisun
- 4.1.1 Hisun Company Information
- 4.1.2 Hisun Business Overview
- 4.1.3 Hisun Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Hisun Carboplatin Injection Product Portfolio
- 4.1.5 Hisun Recent Developments
- 4.2 Yunnan Phytopharmaceutical
- 4.2.1 Yunnan Phytopharmaceutical Company Information
- 4.2.2 Yunnan Phytopharmaceutical Business Overview
- 4.2.3 Yunnan Phytopharmaceutical Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Yunnan Phytopharmaceutical Carboplatin Injection Product Portfolio
- 4.2.5 Yunnan Phytopharmaceutical Recent Developments
- 4.3 Yangzijiang Group
- 4.3.1 Yangzijiang Group Company Information
- 4.3.2 Yangzijiang Group Business Overview
- 4.3.3 Yangzijiang Group Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Yangzijiang Group Carboplatin Injection Product Portfolio
- 4.3.5 Yangzijiang Group Recent Developments
- 4.4 Teva
- 4.4.1 Teva Company Information
- 4.4.2 Teva Business Overview
- 4.4.3 Teva Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teva Carboplatin Injection Product Portfolio
- 4.4.5 Teva Recent Developments
- 4.5 Shanghai Acebright Pharmaceuticals
- 4.5.1 Shanghai Acebright Pharmaceuticals Company Information
- 4.5.2 Shanghai Acebright Pharmaceuticals Business Overview
- 4.5.3 Shanghai Acebright Pharmaceuticals Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shanghai Acebright Pharmaceuticals Carboplatin Injection Product Portfolio
- 4.5.5 Shanghai Acebright Pharmaceuticals Recent Developments
- 4.6 Shandong Ruiying
- 4.6.1 Shandong Ruiying Company Information
- 4.6.2 Shandong Ruiying Business Overview
- 4.6.3 Shandong Ruiying Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shandong Ruiying Carboplatin Injection Product Portfolio
- 4.6.5 Shandong Ruiying Recent Developments
- 4.7 Qilu Pharmaceutical
- 4.7.1 Qilu Pharmaceutical Company Information
- 4.7.2 Qilu Pharmaceutical Business Overview
- 4.7.3 Qilu Pharmaceutical Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Qilu Pharmaceutical Carboplatin Injection Product Portfolio
- 4.7.5 Qilu Pharmaceutical Recent Developments
- 4.8 Mylan
- 4.8.1 Mylan Company Information
- 4.8.2 Mylan Business Overview
- 4.8.3 Mylan Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mylan Carboplatin Injection Product Portfolio
- 4.8.5 Mylan Recent Developments
- 4.9 Jiangsu Lianhuan Pharmaceutical
- 4.9.1 Jiangsu Lianhuan Pharmaceutical Company Information
- 4.9.2 Jiangsu Lianhuan Pharmaceutical Business Overview
- 4.9.3 Jiangsu Lianhuan Pharmaceutical Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jiangsu Lianhuan Pharmaceutical Carboplatin Injection Product Portfolio
- 4.9.5 Jiangsu Lianhuan Pharmaceutical Recent Developments
- 4.10 Fresenius Kabi
- 4.10.1 Fresenius Kabi Company Information
- 4.10.2 Fresenius Kabi Business Overview
- 4.10.3 Fresenius Kabi Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Fresenius Kabi Carboplatin Injection Product Portfolio
- 4.10.5 Fresenius Kabi Recent Developments
- 4.11 Cisen Pharmaceutical
- 4.11.1 Cisen Pharmaceutical Company Information
- 4.11.2 Cisen Pharmaceutical Business Overview
- 4.11.3 Cisen Pharmaceutical Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Cisen Pharmaceutical Carboplatin Injection Product Portfolio
- 4.11.5 Cisen Pharmaceutical Recent Developments
- 4.12 Taj Pharmaceuticals
- 4.12.1 Taj Pharmaceuticals Company Information
- 4.12.2 Taj Pharmaceuticals Business Overview
- 4.12.3 Taj Pharmaceuticals Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Taj Pharmaceuticals Carboplatin Injection Product Portfolio
- 4.12.5 Taj Pharmaceuticals Recent Developments
- 4.13 Hospira(Pfizer)
- 4.13.1 Hospira(Pfizer) Company Information
- 4.13.2 Hospira(Pfizer) Business Overview
- 4.13.3 Hospira(Pfizer) Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Hospira(Pfizer) Carboplatin Injection Product Portfolio
- 4.13.5 Hospira(Pfizer) Recent Developments
- 4.14 Bristol-Myers Squibb SA
- 4.14.1 Bristol-Myers Squibb SA Company Information
- 4.14.2 Bristol-Myers Squibb SA Business Overview
- 4.14.3 Bristol-Myers Squibb SA Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Bristol-Myers Squibb SA Carboplatin Injection Product Portfolio
- 4.14.5 Bristol-Myers Squibb SA Recent Developments
5 Global Carboplatin Injection Market Scenario by Region
- 5.1 Global Carboplatin Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Carboplatin Injection Sales by Region: 2021-2032
- 5.2.1 Global Carboplatin Injection Sales by Region: 2021-2026
- 5.2.2 Global Carboplatin Injection Sales by Region: 2027-2032
- 5.3 Global Carboplatin Injection Revenue by Region: 2021-2032
- 5.3.1 Global Carboplatin Injection Revenue by Region: 2021-2026
- 5.3.2 Global Carboplatin Injection Revenue by Region: 2027-2032
- 5.4 North America Carboplatin Injection Market Facts & Figures by Country
- 5.4.1 North America Carboplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Carboplatin Injection Sales by Country (2021-2032)
- 5.4.3 North America Carboplatin Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Carboplatin Injection Market Facts & Figures by Country
- 5.5.1 Europe Carboplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Carboplatin Injection Sales by Country (2021-2032)
- 5.5.3 Europe Carboplatin Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Carboplatin Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Carboplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Carboplatin Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Carboplatin Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Carboplatin Injection Market Facts & Figures by Country
- 5.7.1 South America Carboplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Carboplatin Injection Sales by Country (2021-2032)
- 5.7.3 South America Carboplatin Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Carboplatin Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Carboplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Carboplatin Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Carboplatin Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Carboplatin Injection Sales by Type (2021-2032)
- 6.1.1 Global Carboplatin Injection Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Carboplatin Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Carboplatin Injection Revenue by Type (2021-2032)
- 6.2.1 Global Carboplatin Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Carboplatin Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Carboplatin Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Carboplatin Injection Sales by Application (2021-2032)
- 7.1.1 Global Carboplatin Injection Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Carboplatin Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Carboplatin Injection Revenue by Application (2021-2032)
- 7.2.1 Global Carboplatin Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Carboplatin Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Carboplatin Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Carboplatin Injection Value Chain Analysis
- 8.1.1 Carboplatin Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Carboplatin Injection Production Mode & Process
- 8.2 Carboplatin Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Carboplatin Injection Distributors
- 8.2.3 Carboplatin Injection Customers
9 Global Carboplatin Injection Analyzing Market Dynamics
- 9.1 Carboplatin Injection Industry Trends
- 9.2 Carboplatin Injection Industry Drivers
- 9.3 Carboplatin Injection Industry Opportunities and Challenges
- 9.4 Carboplatin Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst